| Literature DB >> 35602311 |
Walter D Dawson1, Erin Smith2, Laura Booi2, Maia Mosse3, Helen Lavretsky4, Charles F Reynolds5, Jeffrey Cummings6, Patrick Brannally7, William Hynes3, Eric J Lenze8, Facundo Manes9, Rym Ayadi10, Lori Frank11, Sandra Bond Chapman12, Ian H Robertson2, Lori Rubenstein13, Jorge Jraissati14, Agustin Ibáñez2, Howard Fillit15, Dilip V Jeste16, Anitha Rao17, Michael Berk18, Eric A Storch19, Antonella Santuccione Chadha20, Harris A Eyre18.
Abstract
Within many societies and cultures around the world, older adults are too often undervalued and underappreciated. This exacerbates many key challenges that older adults may face. It also undermines the many positive aspects of late life that are of tremendous value at both an individual and societal level. We propose a new approach to elevate health and well-being in late life by optimizing late-life Brain Capital. This form of capital prioritizes brain skills and brain health in a brain economy, which the challenges and opportunities of the 21st-century demands. This approach incorporates investing in late-life Brain Capital, developing initiatives focused on building late-life Brain Capital.Entities:
Keywords: Aging; Brain health; Innovation; Mental disorders; Neuroscience; Psychiatry
Year: 2022 PMID: 35602311 PMCID: PMC9116879 DOI: 10.1093/geroni/igac016
Source DB: PubMed Journal: Innov Aging ISSN: 2399-5300
Investment Approaches for the Late-Life Brain Capital Investment Plan
| Approach | Process by which approach supports Brain Capital | Exemplar initiatives |
|---|---|---|
| Social impact investing | Outcomes-based funding strategies allow public-sector entities (e.g., governments) to pay only for what works, to the extent that it works; at the same time, they create pathways for the most impactful providers and interventions to grow if they can achieve key policy priorities. These strategies appear to be especially valuable when targeting the social determinants of health—and particularly behavioral health. | Capital Impact Partners ( |
| Taxation and accounting restructuring to support Brain Capital | Exploring the permanent redesignation of business expenditures on employee payroll, health, reskilling, retraining, innovation, and human productive capacity as insurable capital investments. Treating expenditures on the employment, development, health, and productive capacity of people as capital investment to stimulate economic activity. This can be referred to as a Human Capital Accounting Framework, as published recently by the World Economic Forum and Willis Towers Watson ( | A dichotomy exists between the idea that corporations should receive favorable tax treatment for investing in “things” but not for investing in “people” ( |
| Government grant programs | Governmental bodies can issue grants to support Brain Capital initiatives (e.g., technological, nonprofit, etc.). | The U.S. Small Business Innovation Research (SBIR) program is a competitive program that encourages domestic small businesses to engage in Federal Research/ Research and Development with the potential for commercialization ( |
Table 1 has been adapted and modified from Smith, Ali et al. (2021).
Initiatives Focused on Building Late-Life Brain Capital
| Initiative focused on building late-life Brain Capital | Overview of how the initiative builds late-life Brain Capital |
|---|---|
| The Davos Alzheimer’s | A public–private partnership working toward a global response to Alzheimer’s disease (AD) and the challenges it poses to millions of individuals and families globally. The DAC seeks to raise $700 million to fund a 6-year plan to accelerate and diversify innovation in AD-focused research. The three primary components of DAC include a global cohort developed to identify new targets for potential treatments, a global clinical trial support platform to reduce the cost and time to test new treatments in trials and bring them to market and promote health care system preparedness to get novel treatments to individuals. The DAC project will enable novel biomarker development, connect global researchers using the data platform provided by the Alzheimer’s Disease Data Initiative (ADDI), and keep people with the lived experience of AD at the center of its efforts. |
| Alzheimer’s Disease Data Initiative (ADDI) | ADDI, a 501(c)(3) medical research organization in partnership with the University of Washington, is dedicated to advancing scientific breakthroughs in the treatment of Alzheimer’s and related dementias ( |
| Alzheimer’s Drug Discovery Foundation (ADDF) | A notable model that can spur new developments in late-life brain health is that of the ADDF, which utilizes venture philanthropy to fund breakthrough research in academia and the biotech industry with promise for preventing and treating Alzheimer’s disease and other dementias ( |